20. Reiner A, Yekutieli D, Benjamini Y (2003) Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19: 368– 375. 21. Shamir R, Maron-Katz A, Tanay A, Linhart C, Steinfeld I, et al. (2005) EXPANDER–an integrative program suite for microarray data analysis. BMC Bioinformatics 6: 232. 22. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3. 23. David R, Shai E, Aframian DJ, Palmon A (2008) Isolation and cultivation of integrin alpha(6)beta(1)-expressing salivary gland graft cells: A model for use with an artificial salivary gland. Tissue Engineering Part A 14: 331–337. 24. Palmon A, David R, Neumann Y, Stiubea-Cohen R, Krief G, et al. (2011) High- efficiency immunomagnetic isolation of solid tissue-originated integrin-express- ing adult stem cells. Methods 56(2):305–9. 25. Eisbruch A (2005) Intensity-modulated radiation therapy in the treatment of head and neck cancer. Nat Clin Pract Oncol 2: 34–39. 26. Zheng C, Cotrim AP, Rowzee A, Swaim W, Sowers A, et al. (2011) Prevention of radiation-induced salivary hypofunction following hKGF gene delivery to murine submandibular glands. Clin Cancer Res 17: 2842–2851. 27. David R, Shai E, Aframian DJ, Palmon A (2008) Isolation and cultivation of integrin alpha(6)beta(1)-expressing salivary gland graft cells: a model for use with an artificial salivary gland. Tissue Eng Part A 14: 331–337. 28. Yaniv A, Neumann Y, David R, Stiubea-Cohen R, Orbach Y, et al. (2010) Establishment of Immortal Multipotent Rat Salivary Progenitor Cell Line Toward Salivary Gland Regeneration. Tissue Eng Part C Methods 17(1): 69–78. 29. Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, et al. (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12: 127–136. 30. Munter MW, Hoffner S, Hof H, Herfarth KK, Haberkorn U, et al. (2007) Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity- modulated radiotherapy and conventional radiation therapy with and without Amifostine. Int J Radiat Oncol Biol Phys 67: 651–659. 31. Yao Y, Berg EA, Costello CE, Troxler RF, Oppenheim FG (2003) Identification of protein components in human acquired enamel pellicle and whole saliva using novel proteomics approaches. J Biol Chem 278: 5300–5308. 32. Hu S, Xie Y, Ramachandran P, Ogorzalek Loo RR, Li Y, et al. (2005) Large- scale identification of proteins in human salivary proteome by liquid Proteome and Transcriptome in Irradiated Glands chromatography/mass spectrometry and two-dimensional gel electrophoresis- mass spectrometry. Proteomics 5: 1714–1728. 33. Hardt M, Thomas LR, Dixon SE, Newport G, Agabian N, et al. (2005) Toward defining the human parotid gland salivary proteome and peptidome: identification and characterization using 2D SDS-PAGE, ultrafiltration, HPLC, and mass spectrometry. Biochemistry 44: 2885–2899. 34. Vitorino R, Lobo MJ, Ferrer-Correira AJ, Dubin JR, Tomer KB, et al. (2004) Identification of human whole saliva protein components using proteomics. Proteomics 4: 1109–1115. 35. Chen Y, Zhao YH, Kalaslavadi TB, Hamati E, Nehrke K, et al. (2004) Genome- wide search and identification of a novel gel-forming mucin MUC19/Muc19 in glandular tissues. Am J Respir Cell Mol Biol 30: 155–165. 36. Zhou J, Li J, Chen J, Liu Y, Gao W, et al. (2009) Over-expression of CDH22 is associated with tumor progression in colorectal cancer. Tumour Biol 30: 130– 140. 37. Cotroneo E, Proctor GB, Carpenter GH (2010) Regeneration of acinar cells following ligation of rat submandibular gland retraces the embryonic-perinatal pathway of cytodifferentiation. Differentiation 79: 120–130. 38. Azen EA, Amberger E, Fisher S, Prakobphol A, Niece RL (1996) PRB1, PRB2, and PRB4 coded polymorphisms among human salivary concanavalin-A binding, II-1, and Po proline-rich proteins. Am J Hum Genet 58: 143–153. 39. Chan M, Bennick A (2001) Proteolytic processing of a human salivary proline- rich protein precursor by proprotein convertases. Eur J Biochem 268: 3423– 3431. 40. Dickinson DP (2002) Salivary (SD-type) cystatins: over one billion years in the making–but to what purpose? Crit Rev Oral Biol Med 13: 485–508. 41. Hirtz C, Chevalier F, Centeno D, Rofidal V, Egea JC, et al. (2005) MS characterization of multiple forms of alpha-amylase in human saliva. Proteomics 5: 4597–4607. 42. Hartwell LH, Kastan MB (1994) Cell cycle control and cancer. Science 266: 1821–1828. 43. Pawlik TM, Keyomarsi K (2004) Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 59: 928–942. 44. Zhang Z, Wang L, Wei S, Liu Z, Wang LE, et al. (2010) Polymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer. DNA Repair (Amst) 9: 558–566. 45. Yaniv A, Neumann Y, David R, Stiubea-Cohen R, Orbach Y, et al. (2011) Establishment of Immortal Multipotent Rat Salivary Progenitor Cell Line Toward Salivary Gland Regeneration. Tissue Engineering Part C-Methods 17: 69–78. PLoS ONE | www.plosone.org 9 July 2012 | Volume 7 | Issue 7 | e40636